Emanuelle Araujo Lima Bellaguarda

Assistant Professor, Medicine, Gastroenterology Division

Emailemanuelle.bellaguarda@northwestern.edu

Source: Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Inflammatory bowel disease (Crohn's disease and ulcerative colitis), therapeutic drug monitoring, clinical trials

Training Experience

2011	Residency, Boston University Medical Center
2014	Fellowship, University of Chicago
2015	Fellowship, Northwestern University, Feinberg School of Medicine

Education/Academic qualification

MD, Federal University of Ceara

… → 2006

Medicine, MD, Federal University of Ceara, Brazil

… → 2006

Research interests

Inflammatory Bowel Disease

Fingerprint

Dive into the research topics where Emanuelle Araujo Lima Bellaguarda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

5 Finished
8 Active

Prot#M14-533: A Phase 3 multicenter, open-label extension (OLE) study to evaluate the long-term safety and efficacy of ABT-494 in subjects with ulcerative colitis (UC)
Bellaguarda, E. A. L.
AbbVie Inc.
7/29/20 → 7/29/23
Project: Research project
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 52-Week Study to Assess the Efficacy and Safety of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
Bellaguarda, E. A. L.
DrugDev Inc., Arena Pharmaceuticals, Inc.
5/11/20 → 5/11/23
Project: Research project
Protocol M14-234: A Multicenter, Randomized, Double-Blind, Placebo -Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis
Bellaguarda, E. A. L. & Hanauer, S. B.
AbbVie Inc.
7/23/19 → 7/23/22
Project: Research project
Protocol M16-000: A Multicenter, Randomized, Double-Blind, Placebo Controlled 52-Week Maintenance and an Open-Label Extension Study of the Efficacy and Safety of Risankizumab in Subjects with Crohn's Disease Who Responded to Induction Treatment in M16-006
Bellaguarda, E. A. L.
AbbVie Inc.
7/1/19 → 3/4/23
Project: Research project
Semen quality in males with inflammatory bowel disease and inflammatory joint disease: Influence of ustekinumab and tofacitinib treatment
Bellaguarda, E. A. L.
Northwestern Memorial Hospital, Digestive Health Foundation
7/1/19 → 6/30/21
Project: Research project

245 Citations
10 Article
2 Review article
1 Letter

Checkpoint Inhibitor-Induced Colitis
Bellaguarda, E. & Hanauer, S., Feb 1 2020, In: The American journal of gastroenterology. 115, 2, p. 202-210 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
4 Scopus citations
Disordered Eating, Body Dissatisfaction, and Psychological Distress in Patients with Inflammatory Bowel Disease (IBD)
Wabich, J., Bellaguarda, E., Joyce, C., Keefer, L. & Kinsinger, S., Jun 1 2020, In: Journal of Clinical Psychology in Medical Settings. 27, 2, p. 310-317 8 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Recurrent brisk haematochezia in a patient with quiescent Crohn's disease
Gasanova, Z., Lemmer, A. & Bellaguarda, E., Jan 1 2020, (Accepted/In press) In: Frontline Gastroenterology. flgastro-2019-101404.
Research output: Contribution to journal › Article › peer-review
Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis
Limketkai, B. N., Shah, S. C., Hirano, I., Bellaguarda, E. & Colombel, J. F., Dec 1 2019, In: Gut. 68, 12, p. 2152-2160 9 p.
Research output: Contribution to journal › Article › peer-review
11 Scopus citations
Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
Christensen, B., Micic, D., Gibson, P. R., Yarur, A., Bellaguarda, E., Corsello, P., Gaetano, J. N., Kinnucan, J., Rao, V. L., Reddy, S., Singh, S., Pekow, J. & Rubin, D. T., Mar 2018, In: Alimentary Pharmacology and Therapeutics. 47, 6, p. 753-762 10 p.
Research output: Contribution to journal › Article › peer-review
32 Scopus citations